• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pim-1 激酶在炎症信号通路中的作用。

The role of Pim-1 kinases in inflammatory signaling pathways.

机构信息

Department of Immunology, School of Medicine, Keimyung University, Daegu, 42601, Republic of Korea.

Department of Pharmacology, Chonnam University, Gwangju, 61469, Republic of Korea.

出版信息

Inflamm Res. 2024 Oct;73(10):1671-1685. doi: 10.1007/s00011-024-01924-2. Epub 2024 Jul 30.

DOI:10.1007/s00011-024-01924-2
PMID:39079978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11457682/
Abstract

OBJECTIVE AND DESIGN

This observational study investigated the regulatory mechanism of Pim-1 in inflammatory signaling pathways.

MATERIALS

THP-1, RAW 264.7, BV2, and Jurkat human T cell lines were used.

TREATMENT

None.

METHODS

Lipopolysaccharide (LPS) was used to induce inflammation, followed by PIM1 knockdown. Western blot, immunoprecipitation, immunofluorescence, and RT-PCR assays were used to assess the effect of PIM1 knockdown on LPS-induced inflammation.

RESULTS

PIM1 knockdown in macrophage-like THP-1 cells suppressed LPS-induced upregulation of pro-inflammatory cytokines, inducible nitric oxide synthase, cyclooxygenase-2, phosphorylated Janus kinase, signal transducer and activator of transcription 3, extracellular signal-regulated kinase, c-Jun N-terminal kinase, p38, and nuclear factor kappa B p65 (NF-κB p65). It also suppressed upregulation of inhibitor of NF-κB kinase α/β and enhanced the nuclear translocation of NF-κB p65. Moreover, it inhibited the upregulation of Nod-like receptor family pyrin domain-containing 3 (NLRP3) and cleavage of caspase-1 induced by co-treatment of LPS with adenosine triphosphate. Additionally, p-transforming growth factor-β-activated kinase 1 (TAK1) interacted with Pim-1. All three members of Pim kinases (Pim-1, Pim-2, and Pim-3) were required for LPS-mediated inflammation in macrophages; however, unlike Pim-1 and Pim-3, Pim-2 functioned as a negative regulator of T cell activity.

CONCLUSIONS

Pim-1 interacts with TAK1 in LPS-induced inflammatory responses and is involved in MAPK/NF-κB/NLRP3 signaling pathways. Additionally, considering the negative regulatory role of Pim-2 in T cells, further in-depth studies on their respective functions are needed.

摘要

目的和设计

本观察性研究旨在探讨 Pim-1 在炎症信号通路中的调节机制。

材料

使用了 THP-1、RAW 264.7、BV2 和 Jurkat 人 T 细胞系。

处理

无。

方法

使用脂多糖(LPS)诱导炎症,然后敲低 PIM1。使用 Western blot、免疫沉淀、免疫荧光和 RT-PCR 检测 PIM1 敲低对 LPS 诱导炎症的影响。

结果

巨噬细胞样 THP-1 细胞中 PIM1 的敲低抑制了 LPS 诱导的促炎细胞因子、诱导型一氧化氮合酶、环氧化酶-2、磷酸化 Janus 激酶、信号转导和转录激活因子 3、细胞外信号调节激酶、c-Jun N 末端激酶、p38 和核因子 kappa B p65(NF-κB p65)的上调。它还抑制了 NF-κB 激酶α/β抑制剂的上调,并增强了 NF-κB p65 的核转位。此外,它抑制了 LPS 与三磷酸腺苷共同处理诱导的 Nod 样受体家族吡啶结构域包含 3(NLRP3)的上调和半胱天冬酶-1 的切割。此外,p-转化生长因子-β激活激酶 1(TAK1)与 Pim-1 相互作用。三种 Pim 激酶(Pim-1、Pim-2 和 Pim-3)都需要在巨噬细胞中进行 LPS 介导的炎症反应;然而,与 Pim-1 和 Pim-3 不同,Pim-2 作为 T 细胞活性的负调节剂发挥作用。

结论

Pim-1 在 LPS 诱导的炎症反应中与 TAK1 相互作用,并参与 MAPK/NF-κB/NLRP3 信号通路。此外,鉴于 Pim-2 在 T 细胞中的负调节作用,需要进一步深入研究它们各自的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/2fbc6c6da954/11_2024_1924_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/e8fd313ad249/11_2024_1924_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/7b0a32ca72da/11_2024_1924_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/5a39100c7e7f/11_2024_1924_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/196e04b28495/11_2024_1924_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/48d98a5ff4e9/11_2024_1924_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/b64e6c4f220a/11_2024_1924_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/2fbc6c6da954/11_2024_1924_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/e8fd313ad249/11_2024_1924_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/7b0a32ca72da/11_2024_1924_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/5a39100c7e7f/11_2024_1924_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/196e04b28495/11_2024_1924_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/48d98a5ff4e9/11_2024_1924_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/b64e6c4f220a/11_2024_1924_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c19/11457682/2fbc6c6da954/11_2024_1924_Fig7_HTML.jpg

相似文献

1
The role of Pim-1 kinases in inflammatory signaling pathways.Pim-1 激酶在炎症信号通路中的作用。
Inflamm Res. 2024 Oct;73(10):1671-1685. doi: 10.1007/s00011-024-01924-2. Epub 2024 Jul 30.
2
KMU-1170, a Novel Multi-Protein Kinase Inhibitor, Suppresses Inflammatory Signal Transduction in THP-1 Cells and Human Osteoarthritic Fibroblast-Like Synoviocytes by Suppressing Activation of NF-κB and NLRP3 Inflammasome Signaling Pathway.KMU-1170,一种新型的多蛋白激酶抑制剂,通过抑制 NF-κB 和 NLRP3 炎性小体信号通路的激活,抑制 THP-1 细胞和人骨性关节炎成纤维样滑膜细胞中的炎症信号转导。
Int J Mol Sci. 2021 Jan 26;22(3):1194. doi: 10.3390/ijms22031194.
3
Anti-Inflammatory Effects of the Novel PIM Kinase Inhibitor KMU-470 in RAW 264.7 Cells through the TLR4-NF-κB-NLRP3 Pathway.新型 PIM 激酶抑制剂 KMU-470 通过 TLR4-NF-κB-NLRP3 通路对 RAW 264.7 细胞的抗炎作用。
Int J Mol Sci. 2020 Jul 20;21(14):5138. doi: 10.3390/ijms21145138.
4
Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways.颗粒蛋白前体通过 NF-кB 和 MAPK 通路抑制 LPS 诱导的巨噬细胞 M1 极化。
BMC Immunol. 2020 Jun 5;21(1):32. doi: 10.1186/s12865-020-00355-y.
5
Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.槲皮素破坏酪氨酸磷酸化的磷脂酰肌醇 3-激酶和髓样分化因子 88 之间的关联,并抑制 MAPK/AP-1 和 IKK/NF-κB 诱导的 RAW 264.7 细胞中炎症介质的产生。
Immunobiology. 2013 Dec;218(12):1452-67. doi: 10.1016/j.imbio.2013.04.019. Epub 2013 May 9.
6
Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.芦荟下调脂多糖诱导的人巨噬细胞中炎症细胞因子的产生和 NLRP3 炎性体的表达。
Mol Immunol. 2013 Dec;56(4):471-9. doi: 10.1016/j.molimm.2013.05.005. Epub 2013 Aug 1.
7
Plantanone C attenuates LPS-stimulated inflammation by inhibiting NF-κB/iNOS/COX-2/MAPKs/Akt pathways in RAW 264.7 macrophages.滇黄芩素 C 通过抑制 RAW 264.7 巨噬细胞中的 NF-κB/iNOS/COX-2/MAPKs/Akt 通路来减轻 LPS 刺激的炎症反应。
Biomed Pharmacother. 2021 Nov;143:112104. doi: 10.1016/j.biopha.2021.112104. Epub 2021 Aug 30.
8
Green synthesis of gold nanoparticles using leaf extract to inhibit lipopolysaccharide-induced inflammation through NF-κB and JAK/STAT pathways in RAW 264.7 macrophages.利用叶提取物通过 RAW 264.7 巨噬细胞中的 NF-κB 和 JAK/STAT 通路抑制脂多糖诱导的炎症的金纳米粒子的绿色合成。
Int J Nanomedicine. 2019 Apr 26;14:2945-2959. doi: 10.2147/IJN.S199781. eCollection 2019.
9
SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-kappaB pathways in RAW 264.7 macrophages.SM905,一种青蒿素衍生物,通过抑制 RAW 264.7 巨噬细胞中的 MAPK 和 NF-κB 通路来抑制 NO 和促炎细胞因子的产生。
Acta Pharmacol Sin. 2009 Oct;30(10):1428-35. doi: 10.1038/aps.2009.138.
10
Xanthotoxin suppresses LPS-induced expression of iNOS, COX-2, TNF-α, and IL-6 via AP-1, NF-κB, and JAK-STAT inactivation in RAW 264.7 macrophages.黄曲霉毒素通过使RAW 264.7巨噬细胞中的AP-1、NF-κB和JAK-STAT失活,抑制脂多糖诱导的诱导型一氧化氮合酶、环氧化酶-2、肿瘤坏死因子-α和白细胞介素-6的表达。
Int Immunopharmacol. 2017 Aug;49:21-29. doi: 10.1016/j.intimp.2017.05.021. Epub 2017 May 24.

引用本文的文献

1
Tricyclic Isatin Derivatives as Anti-Inflammatory Compounds with High Kinase Binding Affinity.具有高激酶结合亲和力的三环异吲哚酮衍生物作为抗炎化合物
Molecules. 2025 Jul 10;30(14):2914. doi: 10.3390/molecules30142914.

本文引用的文献

1
Pim1 promotes IFN-β production by interacting with IRF3.Pim1 通过与 IRF3 相互作用促进 IFN-β 的产生。
Exp Mol Med. 2022 Nov;54(11):2092-2103. doi: 10.1038/s12276-022-00893-y. Epub 2022 Nov 29.
2
Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity.Toll样受体信号传导及其在细胞介导免疫中的作用。
Front Immunol. 2022 Mar 3;13:812774. doi: 10.3389/fimmu.2022.812774. eCollection 2022.
3
Targeting Toll-like Receptor (TLR) Pathways in Inflammatory Arthritis: Two Better Than One?靶向 Toll 样受体 (TLR) 通路治疗炎症性关节炎:双管齐下?
Biomolecules. 2021 Aug 30;11(9):1291. doi: 10.3390/biom11091291.
4
PIM Kinases in Multiple Myeloma.多发性骨髓瘤中的PIM激酶
Cancers (Basel). 2021 Aug 26;13(17):4304. doi: 10.3390/cancers13174304.
5
NLRP3 inflammasome activation and cell death.NLRP3 炎性小体的激活与细胞死亡。
Cell Mol Immunol. 2021 Sep;18(9):2114-2127. doi: 10.1038/s41423-021-00740-6. Epub 2021 Jul 28.
6
PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity.PIM 激酶通过调节 JAK-STAT 和 NF-κB 活性促进原发性纵隔大 B 细胞淋巴瘤的存活和免疫逃逸。
Am J Pathol. 2021 Mar;191(3):567-574. doi: 10.1016/j.ajpath.2020.12.001. Epub 2020 Dec 8.
7
Anti-Inflammatory Effects of the Novel PIM Kinase Inhibitor KMU-470 in RAW 264.7 Cells through the TLR4-NF-κB-NLRP3 Pathway.新型 PIM 激酶抑制剂 KMU-470 通过 TLR4-NF-κB-NLRP3 通路对 RAW 264.7 细胞的抗炎作用。
Int J Mol Sci. 2020 Jul 20;21(14):5138. doi: 10.3390/ijms21145138.
8
A serine/threonine protein PIM kinase as a biomarker of cancer and a target for anti-tumor therapy.丝氨酸/苏氨酸蛋白 PIM 激酶作为癌症的生物标志物和抗肿瘤治疗的靶点。
Life Sci. 2020 Aug 15;255:117866. doi: 10.1016/j.lfs.2020.117866. Epub 2020 May 29.
9
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.TLR4 与 NLRP3 炎性小体及补体信号通路在阿尔茨海默病中的相互作用。
Front Immunol. 2020 Apr 23;11:724. doi: 10.3389/fimmu.2020.00724. eCollection 2020.
10
TLR4-Targeting Therapeutics: Structural Basis and Computer-Aided Drug Discovery Approaches.TLR4 靶向治疗药物:结构基础与计算机辅助药物发现方法。
Molecules. 2020 Jan 31;25(3):627. doi: 10.3390/molecules25030627.